Exosome-derived miR-25-3p and miR-92a-3p stimulate liposarcoma progression

Despite the development of combined modality treatments against liposarcoma (LPS) in recent years, a significant proportion of patients respond only modestly to such approaches, possibly contributing to local or distant recurrence. Early detection of recurrent or metastatic disease could improve pat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Res
Glavni autori: Casadei, Lucia, Calore, Federica, Creighton, Chad J., Guescini, Michele, Batte, Kara, Iwenofu, O. Hans, Zewdu, Abeba, Braggio, Danielle A., Lynn Bill, Kate, Fadda, Paolo, Lovat, Francesca, Lopez, Gonzalo, Gasparini, Pierluigi, Chen, James L., Kladney, Raleigh D., Leone, Gustavo, Lev, Dina, Croce, Carlo M., Pollock, Raphael E.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033276/
https://ncbi.nlm.nih.gov/pubmed/28588009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-2984
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items